Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adynovate Continuation Study in Severe Hemophilia A
NCT01945593Phase 3Completed
- Sponsor
- Takeda
- Start
- Oct 2013
- Primary completion
- Mar 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 23
01
Overview
A Phase 3 trial of recombinant coagulation factor viii in hemophilia A, sponsored by Takeda. Started Oct 2013; status: completed.
02
Drugs
recombinant coagulation factor viii
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT01945593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01945593.